Literature DB >> 9051860

Propionibacterium avidum sacroiliitis and osteomyelitis.

O Estoppey1, G Rivier, C H Blanc, F Widmer, A Gallusser, A K So.   

Abstract

The anaerobic Gram-positive bacterium Propionibacterium avidum is a common inhabitant of the skin with low pathogenicity. We report a case of P. avidum sacroilitis, psoas abscess and osteomyelitis in a 67-year-old male who had recently undergone surgical repair of an inguinal hernia. The organism was recovered from blood cultures, a bone biopsy specimen and specimens from the abscess. The spectrum of bone and joint infections caused by Propionibacterium is discussed. Infection by Propionibacterium spp. should be considered in patients with bone and joint infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9051860

Source DB:  PubMed          Journal:  Rev Rhum Engl Ed        ISSN: 1169-8446


  4 in total

Review 1.  Clinical and Biological Features of Cutibacterium (Formerly Propionibacterium) avidum, an Underrecognized Microorganism.

Authors:  Stéphane Corvec
Journal:  Clin Microbiol Rev       Date:  2018-05-30       Impact factor: 26.132

2.  Non-purulent low-grade infection as cause of pain following shoulder surgery: preliminary results.

Authors:  Alberto G Schneeberger; Michael K Gilbart; Ralph Sheikh; Christian Gerber; Christian Ruef
Journal:  Chir Organi Mov       Date:  2009-04

3.  Propionibacterium avidum: A Virulent Pathogen Causing Hip Periprosthetic Joint Infection.

Authors:  Yvonne Achermann; Jared Liu; Reinhard Zbinden; Patrick O Zingg; Alexia Anagnostopoulos; Emma Barnard; Reto Sutter; Huiying Li; Andrew McDowell; Annelies S Zinkernagel
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

4.  Complete Genome Sequence of Propionibacterium avidum Strain 44067, Isolated from a Human Skin Abscess.

Authors:  Lilla Ordögh; Judit Hunyadkürti; Andrea Vörös; Balázs Horváth; Attila Szucs; Edit Urbán; Attila Kereszt; Eva Kondorosi; István Nagy
Journal:  Genome Announc       Date:  2013-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.